BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28464843)

  • 1. Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b.
    Levan K; Mehryar M; Mateoiu C; Albertsson P; Bäck T; Sundfeldt K
    BMC Cancer; 2017 May; 17(1):303. PubMed ID: 28464843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of NaPi2b protein (MX35 antigen) expression and subcellular localization in human normal and cancer tissues.
    Kiyamova R; Shyian M; Lyzogubov VV; Usenko VS; Gout T; Filonenko V
    Exp Oncol; 2011 Sep; 33(3):157-61. PubMed ID: 21956469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.
    Yin BW; Kiyamova R; Chua R; Caballero OL; Gout I; Gryshkova V; Bhaskaran N; Souchelnytskyi S; Hellman U; Filonenko V; Jungbluth AA; Odunsi K; Lloyd KO; Old LJ; Ritter G
    Cancer Immun; 2008 Feb; 8():3. PubMed ID: 18251464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico analysis and immunohistochemical characterization of NaPi2b protein expression in ovarian carcinoma with monoclonal antibody Mx35.
    Soares IC; Simões K; de Souza JE; Okamoto OK; Wakamatsu A; Tuma M; Ritter G; Alves VA
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):165-72. PubMed ID: 22553815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of monoclonal antibodies against tumor-associated antigen MX35/sodium-dependent phosphate transporter NaPi2b.
    Gryshkova V; Lituiev D; Savinska L; Ovcharenko G; Gout I; Filonenko V; Kiyamova R
    Hybridoma (Larchmt); 2011 Feb; 30(1):37-42. PubMed ID: 21466284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The study of phosphate transporter NAPI2B expression in different histological types of epithelial ovarian cancer.
    Gryshkova V; Goncharuk I; Gurtovyy V; Khozhayenko Y; Nespryadko S; Vorobjova L; Usenko V; Gout I; Filonenko V; Kiyamova R
    Exp Oncol; 2009 Mar; 31(1):37-42. PubMed ID: 19300415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of monoclonal antibodies specific for the human sodium-dependent phosphate co-transporter NaPi2b.
    Kiyamova R; Gryshkova V; Ovcharenko G; Lituyev D; Malyuchik S; Usenko V; Khozhayenko Y; Gurtovyy V; Yin B; Ritter G; Old L; Filonenko V; Gout I
    Hybridoma (Larchmt); 2008 Aug; 27(4):277-84. PubMed ID: 18724815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors.
    Giurgea LN; Ungureanu C; Mihailovici MS
    Rom J Morphol Embryol; 2012; 53(4):967-73. PubMed ID: 23303020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer.
    Lopes dos Santos M; Yeda FP; Tsuruta LR; Horta BB; Pimenta AA; Degaki TL; Soares IC; Tuma MC; Okamoto OK; Alves VA; Old LJ; Ritter G; Moro AM
    PLoS One; 2013; 8(7):e70332. PubMed ID: 23936189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200.
    Lindegren S; Andrade LN; Bäck T; Machado CM; Horta BB; Buchpiguel C; Moro AM; Okamoto OK; Jacobsson L; Cederkrantz E; Washiyama K; Aneheim E; Palm S; Jensen H; Tuma MC; Chammas R; Hultborn R; Albertsson P
    PLoS One; 2015; 10(5):e0126298. PubMed ID: 25970341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian Cancers.
    Lin K; Rubinfeld B; Zhang C; Firestein R; Harstad E; Roth L; Tsai SP; Schutten M; Xu K; Hristopoulos M; Polakis P
    Clin Cancer Res; 2015 Nov; 21(22):5139-50. PubMed ID: 26156394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort.
    Heynemann S; Yu H; Churilov L; Rivalland G; Asadi K; Mosher R; Hirsch F; Rivard C; Mitchell P
    Clin Lung Cancer; 2022 Mar; 23(2):e90-e98. PubMed ID: 34953676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors.
    Yang G; Zhang H; Liu Y; Zhou J; He W; Quick CM; Xie D; Smoller BR; Fan CY
    Arch Gynecol Obstet; 2013 May; 287(5):989-95. PubMed ID: 23208459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
    Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
    Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer.
    Nurgalieva AK; Popov VE; Skripova VS; Bulatova LF; Savenkova DV; Vlasenkova RA; Safina SZ; Shakirova EZ; Filonenko VV; Bogdanov MV; Kiyamova RG
    Biochem Biophys Rep; 2021 Dec; 28():101104. PubMed ID: 34504954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells.
    Bulatova L; Savenkova D; Nurgalieva A; Reshetnikova D; Timonina A; Skripova V; Bogdanov M; Kiyamova R
    Front Mol Biosci; 2022; 9():895911. PubMed ID: 35911971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non-cancer tissue.
    Yang Q; Zhao J; Cui M; Gi S; Wang W; Han X
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1959-64. PubMed ID: 26554540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.